Follicular Lymphoma Treatment Market 2021 – Rising Prevalence Of This Disease Is Expected To Fuel The Market Growth

Overview:

Follicular lymphoma a type of a cancer where white blood cells known as lymphocytes are affected and result into abnormal growth and multiplication of these cells. Lymphocytes help our body to fight infections. Lymphoma is categorised into two types, Non-Hodgkin and Hodgkin lymphoma. Follicular lymphoma belong to Non-Hodgkin type. Follicular lymphoma symptoms include expansion of the lymph nodes in groin, abdomen and in the neck, weight loss, shortness of breath, fatigue and night sweats.

Request For FREE Sample Copy  

The treatment of follicular lymphoma depends on the growth rate of cancer and depth of related symptoms. Currently, follicular lymphoma is treated with chemotherapy and radiation therapy. However, in most of the cases follicular lymphoma is treated with alone radiation therapy. Chemotherapy or a monoclonal antibody treatment, either alone or both together are used for the treatment of advanced stage of cancer cases. Monoclonal antibodies are more efficient than chemotherapy, since they directly target tumor cells increasing immune cells that destroy tumor and increase the response to treatment.

Drivers:

Growing use of monoclonal antibodies such as Rituximab as therapeutic agent for targeted treatments is expected to augment growth of the global follicular lymphoma treatment market. For instance, in 2016, the National Center for Biotechnology Information (NCBI) reported that using monoclonal antibodies as therapeutics, prevents side effects, which are normally shown by conventional treatments like chemotherapy and radiation, making monoclonal antibodies like Rituximab, an anti-CD20 antibody successful therapeutics for cancer treatment.

Furthermore, increasing prevalence of relapsed follicular lymphoma, which is responsible for repeated treatment for the same patient is expected to boost growth of the global market of follicular lymphoma treatment.

Restraints:

High-cost treatment and access to the drugs are the factors expected to hamper growth of the global follicular lymphoma treatment market.

The PDF Brochure for the study can be requested Here 

Market Taxonomy:

Follicular lymphoma treatment is divided into treatment type, end user, and geography

By treatment type:

• Radiation

• Targeted therapy

• Chemotherapy

• Monoclonal antibody

• Stem cell transplant

By end user:

• Hospitals

• Specialty centers

• Clinics

• Cancer Research Institutes

Regional analysis:

The global follicular lymphoma treatment market is regionally divided into North America, Europe, Latin America, Middle East, Asia Pacific and Africa.

Among regions, North America is expected to witness strong growth in global market of follicular lymphoma treatment due to increasing prevalence of follicular lymphoma. For instance, in 2917, the American Cancer Society (ACS) estimated follicular lymphoma is expected to affect 72,240 individuals including children and adults.

Moreover, Asia Pacific is witnessing robust growth in the global follicular lymphoma treatment market during the forecast time. This is attributed to increasing research activities conducted by private research organizations and government of China to control the follicular lymphoma cancer.

Major players:

Major players active in the global follicular lymphoma treatment market are Spectrum Pharmaceuticals, CTI Biopharma, AbbVie Inc., Amgen, Seattle Genetics, Bayer AG’S, Roche, Johnson and Johnson, Celgene, Novartis, Merck & Co. (MRK), and Pharmacyclics/ Bristol-Myers Squibb (BMY)

In 2017, Bayer AG’s has launched an innovative drug, Aliqopa, also known as copanlisib, which is a kinase inhibitor that block certain enzymes responsible in promoting cell growth.

Buy This Research Study Report For Quick Access 

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Follicular Lymphoma Treatment Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Follicular Lymphoma Treatment Industry Impact

Chapter 2 Global Follicular Lymphoma Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Follicular Lymphoma Treatment (Volume and Value) by Type
2.3 Global Follicular Lymphoma Treatment (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Follicular Lymphoma Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Follicular Lymphoma Treatment Market Analysis
Chapter 6 East Asia Follicular Lymphoma Treatment Market Analysis
Chapter 7 Europe Follicular Lymphoma Treatment Market Analysis
Chapter 8 South Asia Follicular Lymphoma Treatment Market Analysis
Chapter 9 Southeast Asia Follicular Lymphoma Treatment Market Analysis
Chapter 10 Middle East Follicular Lymphoma Treatment Market Analysis
Chapter 11 Africa Follicular Lymphoma Treatment Market Analysis
Chapter 12 Oceania Follicular Lymphoma Treatment Market Analysis
Chapter 13 South America Follicular Lymphoma Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Follicular Lymphoma Treatment Business
Chapter 15 Global Follicular Lymphoma Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology